 STONY BROOK, N.Y.--BUSINESS WIRE--- APDN COVID19--Applied DNA Sciences, Inc. NASDAQ: APDN the Company, a leader in Polymerase Chain Reaction PCR-based DNA manufacturing, announced today the closing of its previously announced registered direct offering with a group of institutional investors of 1,810,000 shares of common stock at a price of 8.30 per share, priced at-the-market under Nasdaq rules, resulting in total gross proceeds of approximately 15 million, before deducting the placement agents f 